Literature DB >> 16188938

p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling.

Davide Barberis1, Andrea Casazza, Raffaella Sordella, Simona Corso, Stefania Artigiani, Jeff Settleman, Paolo M Comoglio, Luca Tamagnone.   

Abstract

Plexins are transmembrane receptors for semaphorins, guiding cell migration and axon extension. Plexin activation leads to the disassembly of integrin-based focal adhesive structures and to actin cytoskeleton remodelling and inhibition of cell migration; however, the underlying molecular mechanisms are unclear. We consistently observe a transient decrease of cellular RhoA-GTP levels upon plexin activation in adherent cells. One of the main effectors of RhoA downregulation is p190, a ubiquitously expressed GTPase activating protein (GAP). We show that, in p190-deficient fibroblasts, the typical functional activities mediated by plexins (such as cell collapse and inhibition of integrin-based adhesion) are blocked or greatly impaired. Notably, the functional response can be rescued in these cells by re-expressing exogenous p190, but not a mutant form specifically lacking RhoGAP activity. We furthermore demonstrate that semaphorin function is blocked in epithelial cells, primary endothelial cells and neuroblasts upon treatment with small interfering RNAs that knockdown p190 expression. Finally, we show that p190 transiently associates with plexins, and its RhoGAP activity is increased in response to semaphorin stimulation. We conclude that p190-RhoGAP is crucially involved in semaphorin signalling to the actin cytoskeleton, via interaction with plexins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188938     DOI: 10.1242/jcs.02590

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  42 in total

Review 1.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

2.  Rho/RacGAPs: embarras de richesse?

Authors:  Roland Csépányi-Kömi; Magdolna Lévay; Erzsébet Ligeti
Journal:  Small GTPases       Date:  2012-07-01

Review 3.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 4.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 5.  Rho and Ras GTPases in axon growth, guidance, and branching.

Authors:  Alan Hall; Giovanna Lalli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 6.  Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.

Authors:  Aurélien Bidaud-Meynard; Fabien Binamé; Valérie Lagrée; Violaine Moreau
Journal:  Small GTPases       Date:  2017-03-13

7.  ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.

Authors:  Thomas Worzfeld; Jakub M Swiercz; Mario Looso; Beate K Straub; Kishor K Sivaraj; Stefan Offermanns
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

8.  ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells.

Authors:  Akio Shimizu; Akiko Mammoto; Joseph E Italiano; Elke Pravda; Andrew C Dudley; Donald E Ingber; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

Review 9.  Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

Authors:  Mélanie Franco; Luca Tamagnone
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

10.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.